Albert Schuette, Jr., MD

Doug Farquhar, MD, MPH, is a board certified surgeon in otorhinolaryngology, head and neck surgery at Piedmont Atlanta Hospital. He has expertise in ear, nose, and throat diseases and conditions, with particular specialty in nose and sinus conditions, as well as and skull base tumors and cancers. Dr. Farquhar earned his medical degree at the University of Pennsylvania, while simultaneously obtaining a masters in public health. He completed his surgical internship and residency at the University of North Carolina, while also completing an NIH-funded research fellowship investigating head and neck cancers and sinus disease. During his residency, Dr. Farquhar honed particular expertise in sinus surgery and skull base surgery in an enfolded fellowship at the Savannah Sinus Institute. Dr. Farquhar also received advanced fellowship training in sinus surgery and skull base surgery Thomas Jefferson University Hospital. While at Thomas Jefferson, he helped to lead research into treatments for COVID-related smell loss. Dr. Farquhar has published over 50 peer-reviewed medical journal articles, as well as numerous other abstracts, textbook chapters, and has presented at numerous national conferences. Dr. Farquhar is a member of the North American Skull Base Society, the American Rhinologic Society, American Academy of Otolaryngology-Head and Neck Surgery, and the American Medical Association. In his spare time, Dr. Farquhar enjoys spending time with his wife and newborn son, hiking, and gardening. Dr. Farquhar welcomes new patients and accepts most insurance plans. He is committed to respectful and cutting-edge medical and surgical care.

Dr. Stiefel is a fellowship trained, board certified Neurosurgeon specializing in Cerebrovascular and Endovascular Neurosurgery and Neurosurgical Oncology. Dr. Stiefel completed his Neurosurgery training at the University of Pennsylvania where he gained extensive experience in cerebrovascular diseases and the treatment of brain tumors at the University of Pennsylvania's Abramson Cancer Center. Following residency, Dr. Stiefel completed a fellowship in Endovascular Neurosurgery at the Barrow Neurological Institute in Phoenix, Arizona. Dr. Stiefel received additional specialty training in stereotactic radiosurgery utilizing both Cyberknife and Gamma Knife techniques for the treatment of brain tumors and vascular diseases. Dr. Stiefel's training enables him to treat vascular disorders and brain tumors with cranial and microsurgery, endovascular neurosurgery, as well as stereotactic radiosurgery. Dr. Stiefel specializes in the treatment of disorders of the blood vessels of the brain, neck and spine such as brain aneurysms, arteriovenous malformations, arteriovenous fistulas, carotid stenosis, as well as primary brain tumors, metastatic brain tumors, and meningiomas. He performs traditional cranial neurosurgery for brain tumors, aneurysms, AVMs and cavernous malformations as well as endovascular techniques such as aneurysm coiling, stenting and flow diversion, acute stroke treatment, carotid artery stenting, transverse sinus stenting, as well as embolization of arteriovenous malformations, arteriovenous fistulas, brain tumors, head and neck tumors and subdural hematomas. Dr. Stiefel is a senior member of the Society of NeuroInterventional Surgery and was awarded Subspecialty Certification in NeuroEndovascular Surgery by The Society of Neurological Surgeons Committee on Advanced Subspecialty Training. Dr. Stiefel is accepting new patients and welcomes most major insurance plans.

Aaron Mammoser, MD, MS, is a Neuro-Oncologist specializing in the comprehensive care of people with primary tumors of the brain and spine, CNS lymphoma, brain and spine metastases, leptomeningeal dissemination of cancer (LMD). He also manages patients with neurologic complications of cancer, including headaches, seizures, neuropathy, and other complications from both the diagnosis itself and the subsequent treatment. Dr. Mammoser is a board-certified Neurologist, having completed his internship and residency at the University of Michigan. Following residency, he completed a fellowship in Neuro-Oncology at MD Anderson Cancer Center in Houston, TX. During fellowship, he had the privilege of training under multiple faculty that are currently leading some of the most prestigious Neuro-Oncology programs in the country. This invaluable experience afforded the opportunity during training to experience different perspectives of multiple thought leaders in the Neuro-Oncology field and their different approaches to addressing similar challenges in these complicated patients. After fellowship, he returned to the University of Michigan and practiced out of the University of Michigan Comprehensive Cancer Center for 5 ½ years. During his time on faculty, he received a MS in Clinical Research Design and Statistical Analysis through the University of Michigan School of Public Health. During his time at Michigan, he was involved in numerous clinical trials and other clinical research projects. He served as the PI or Co-I on many industry-sponsored, cooperative group, and investigator initiated Neuro-Oncology clinical trials. In 2016 he joined the LSU Neurosurgery Department of LSU Healthcare in New Orleans as an associate professor and held the prestigious Kelsey Bradly Favrot endowed chair in Neuro-Oncology. Tasked with developing a Brain Tumor Program, LSU was the first, and at times only, brain tumor program in the state of Louisiana to offer a robust portfolio of clinical trials for people with primary brain tumors and brain metastases, providing patients in Louisiana and the Gulf South region cutting edge Neuro-Oncology care. Dr. Mammoser joined the Piedmont Brain Tumor Center in April 2023. He brings with him a wealth of clinical experience, having been in clinic practice for 19+ years, over 15 years of which has been dedicated to brain tumor patients. He is a member of the American Society of Clinical Oncology and the Society for Neuro-Oncology and has served on numerous national committees for both ASCO and SNO. He has extensive experience in clinical research, having been the PI of over 16 clinical studies for people with brain tumors of all types, and maintains a special interest in clinical trials for treatment of primary and metastatic brain tumor and spine tumors. Instilled in him during training, and refined through years of practice, Dr. Mammoser prides himself on helping people maintain their quality of life and mitigate short and long-term effects of their diagnosis and its subsequent treatment while continuing to provide state of the art care.